21,997
Views
19
CrossRef citations to date
0
Altmetric
PSYCHOTHERAPEUTICS COLUMN

Effective Strategies for Nurses Empowering Clients With Schizophrenia: Medication Use as a Tool in Recovery

, PhD, RN, , RN-BC, PMHN-BC, MSN, FNP-BC & , PhD, RN, PMHNP-BC, FAANP, FIAAN

REFERENCES

  • Adams, J. R., & Drake, R. E. (2006). Shared decision-making and evidence-based practice. Community Mental Health Journal, 42(1), 87–105.
  • Adams, J. R., Drake, R. E., & Wolford, G. L. (2007). Shared decision-making preferences of people with severe mental illness. Psychiatric Services, 58(9), 1219–1221.
  • Ahn, S., Basu, R., Smith, M. L., Jiang, L., Lorig, K., Whitelaw, N., & Ory, M. G. (2013). The impact of chronic disease self-management programs: Healthcare savings through a community-based intervention. BMC Public Health, 13, 1141.
  • American Psychiatric Association. (2005). Position statement on use of the concept of recovery. Retrieved February 16, 2016, from http://www.psychiatry .org/file%20library/about-apa/organization-documents-policies/policies/pos ition-2005-recovery-concept.pdf
  • American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders ( 5th ed.). Washington, DC: American Psychiatric Association.
  • American Psychiatric Nurses Association. (2011). Recovery to practice pledge. Retrieved February 12, 2016, from http://www.apna.org/i4a/pages/ index.cfm?pageID=4606
  • Chien, W. T., Leung, S. F., Yeung, F. K., & Wong, W. K. (2013). Current approaches to treatments for schizophrenia spectrum disorders, part II: Psychosocial interventions and patient-focused perspectives in psychiatric care. Neuropsychiatric Disease and Treatment, 9, 1463–1481.
  • Correll, C. U. (2010). From receptor pharmacology to improved outcomes: Individualising the selection, dosing, and switching of antipsychotics. European Psychiatry, 25(suppl 2), S12–S21.
  • Correll, C. U. (2014). Mechanism of action of antipsychotic medications. Journal of Clinical Psychiatry, 75(9), e23.
  • Curtis, L. C., Wells, S. M., Penney, D. J., Ghose, S. S., Mistler, L. A., Mahone, I. H., & Lesko, S. (2010). Pushing the envelope: Shared decision making in mental health. Psychiatric Rehabilitation Journal, 34(1), 14–22.
  • Deegan, P. E. (2005). The importance of personal medicine: a qualitative study of resilience in people with psychiatric disabilities. Scandinavian Journal of Public Health. Supplement, 66, 29–35.
  • Deegan, P. E., & Drake, R. E. (2006). Shared decision making and medication management in the recovery process. Psychiatric Services, 57(11), 1636–1639.
  • Emsley, R., Chiliza, B., & Asmal, L. (2013). The evidence for illness progression after relapse in schizophrenia. Schizophrenia Research, 148(1–3), 117–121.
  • Emsley, R., Chiliza, B., Asmal, L., & Harvey, B. H. (2013). The nature of relapse in schizophrenia. BMC Psychiatry, 13, 50.
  • Fenton, W. S., & Schooler, N. R. (2000). Evidence-based psychosocial treatment for schizophrenia. Schizophrenia Bulletin, 26(1), 1–3.
  • Freedom Commission. (2003, July). Achieving the promise: Transforming mental health care in America (No. 2006). The President's New Freedom Commission on Mental Health.
  • Gaspar, P. A., Bustamante, M. L., Silva, H., & Aboitiz, F. (2009). Molecular mechanisms underlying glutamatergic dysfunction in schizophrenia: Therapeutic implications. Journal of Neurochemistry, 111(4), 891–900.
  • Haddad, P. M., Brain, C., & Scott, J. (2014). Nonadherence with antipsychotic medication in schizophrenia: Challenges and management strategies. Patient Related Outcome Measures, 5, 43–62.
  • Haller, C. S., Padmanabhan, J. L., Lizano, P., Torous, J., & Keshavan, M. (2014). Recent advances in understanding schizophrenia. F1000Prime Reports, 6, 57.
  • Hamann, J., Cohen, R., Leucht, S., Busch, R., & Kissling, W. (2005). Do patients with schizophrenia wish to be involved in decisions about their medical treatment? American Journal of Psychiatry, 162(12), 2382–2384.
  • Hasan, A., Falkai, P., Wobrock, T., Lieberman, J., Glenthoj, B., Gattaz, W. F., & Wfsbp Task Force on Treatment Guidelines for Schizophrenia. (2013). World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: Update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects. World Journal of Biological Psychiatry, 14(1), 2–44.
  • Higashi, K., Medic, G., Littlewood, K. J., Diez, T., Granstrom, O., & De Hert, M. (2013). Medication adherence in schizophrenia: Factors influencing adherence and consequences of nonadherence, a systematic literature review. Therapeutic Advances in Psychopharmacology, 3(4), 200–218.
  • Kikkert, M. J., Schene, A. H., Koeter, M. W., Robson, D., Born, A., Helm, H., & Gray, R. J. (2006). Medication adherence in schizophrenia: Exploring patients’, carers’ and professionals’ views. Schizophrenia Bulletin, 32(4), 786–794.
  • Kim, D. H., Maneen, M. J., & Stahl, S. M. (2009). Building a better antipsychotic: receptor targets for the treatment of multiple symptom dimensions of schizophrenia. Neurotherapeutics, 6(1), 78–85.
  • Kirk Morton, N., & Zubek, D. (2013). Adherence challenges and long-acting injectable antipsychotic treatment in patients with schizophrenia. Journal of Psychosocial Nursing and Mental Health Services, 51(3), 13–18.
  • Kishimoto, T., Nitta, M., Borenstein, M., Kane, J. M., & Correll, C. U. (2013). Long-acting injectable versus oral antipsychotics in schizophrenia: A systematic review and meta-analysis of mirror-image studies. Journal of Clinical Psychiatry, 74(10), 957–965.
  • Kreyenbuhl, J., Buchanan, R. W., Dickerson, F. B., Dixon, L. B., & Schizophrenia Patient Outcomes Research Team. (2010). The Schizophrenia Patient Outcomes Research Team (PORT): Updated treatment recommendations 2009. Schizophrenia Bulletin, 36(1), 94–103.
  • Kurtz, M. M., & Richardson, C. L. (2012). Social cognitive training for schizophrenia: A meta-analytic investigation of controlled research. Schizophrenia Bulletin, 38(5), 1092–1104.
  • Lecomte, T., Corbiere, M., Simard, S., & Leclerc, C. (2014). Merging evidence-based psychosocial interventions in schizophrenia. Behavioral Science (Basel), 4(4), 437–447.
  • Lehman, A. F., Kreyenbuhl, J., Buchanan, R. W., Dickerson, F. B., Dixon, L. B., Goldberg, R., & Steinwachs, D. M. (2004). The Schizophrenia Patient Outcomes Research Team (PORT): Updated treatment recommendations 2003. Schizophrenia Bulletin, 30(2), 193–217.
  • Lehman, A. F., & Steinwachs, D. M. (1998). Translating research into practice: The Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations. Schizophrenia Bulletin, 24(1), 1–10.
  • MacDonald-Wilson, K. L., Deegan, P. E., Hutchison, S. L., Parrotta, N., & Schuster, J. M. (2013). Integrating personal medicine into service delivery: Empowering people in recovery. Psychiatric Rehabilitation Journal, 36(4), 258–263.
  • Mahone, I. H. (2008). Shared decision making and serious mental illness. Archives of Psychiatric Nursing, 22(6), 334–343.
  • Mahone, I. H., Farrell, S., Hinton, I., Johnson, R., Moody, D., Rifkin, K., & Barker, M. R. (2011). Shared decision making in mental health treatment: Qualitative findings from stakeholder focus groups. Archives of Psychiatric Nursing, 25(6), e27–e36.
  • Modinos, G., Iyegbe, C., Prata, D., Rivera, M., Kempton, M. J., Valmaggia, L. R., & McGuire, P. (2013). Molecular genetic gene-environment studies using candidate genes in schizophrenia: A systematic review. Schizophrenia Research, 150(2-3), 356–365.
  • Mulley, A. G., Trimble, C., & Elwyn, G. (2012). Stop the silent misdiagnosis: patients’ preferences matter. BMJ (Clinical Research Ed.), 345, e6572.
  • National Institutes for Mental Health. (2014). Schizophrenia. Retrieved November 04, 2014, from http://www.nimh.nih.gov/health/topics/ schizophrenia/index.shtml
  • Offord, S., Lin, J., Mirski, D., & Wong, B. (2013). Impact of early nonadherence to oral antipsychotics on clinical and economic outcomes among patients with schizophrenia. Advances in Therapy, 30(3), 286–297.
  • Olesen, J., Gustavsson, A., Svensson, M., Wittchen, H. U., Jönsson, B., on behalf of the CDBE2010 Study Group, & the European Brain Council. (2012). The economic cost of brain disorders in Europe. European Journal of Neurology, 19(1), 155–162.
  • Park, S. G., Derman, M., Dixon, L. B., Brown, C. H., Klingaman, E. A., Fang, L. J., & Kreyenbuhl, J. (2014). Factors associated with shared decision-making preferences among veterans with serious mental illness. Psychiatric Services, 65(12), 1409–1413.
  • Peplau, H. (1952). Interpersonal relations in nursing. New York, NY: GP Putnam & Sons.
  • Schauer, C., Everett, A., del Vecchio, P., & Anderson, L. (2007). Promoting the value and practice of shared decision-making in mental health care. Psychiatric Rehabilitation Journal, 31(1), 54–61.
  • Shuler, K. M. (2014). Approaches to improve adherence to pharmacotherapy in patients with schizophrenia. Patient Preference and Adherence, 8, 701–714.
  • Substance Abuse and Mental Health Services Administration. (2012). Shared decision making in mental health. Retrieved March 18, 2015, from http://media.samhsa.gov/consumersurvivor/sdm/StartHere.html
  • Townsend, W., & Glasser, N. (2003). Recovery: The heart and soul of treatment. Psychiatric Rehabilitation Journal, 27(1), 83–86.
  • Velligan, D. I., Weiden, P. J., Sajatovic, M., Scott, J., Carpenter, D., Ross, R., & Docherty, J. P. (2009). The expert consensus guideline series: Adherence problems in patients with serious and persistent mental illness. Journal of Clinical Psychiatry, 70(suppl 4), 1–46; quiz 47-48.
  • Velligan, D. I., Weiden, P. J., Sajatovic, M., Scott, J., Carpenter, D., Ross, R., & Docherty, J. P. (2010). Strategies for addressing adherence problems in patients with serious and persistent mental illness: Recommendations from the expert consensus guidelines. Journal of Psychiatric Practice, 16(5), 306– 324.
  • Walder, D. J., Faraone, S. V., Glatt, S. J., Tsuang, M. T., & Seidman, L. J. (2014). Genetic liability, prenatal health, stress and family environment: Risk factors in the Harvard Adolescent Family High Risk for schizophrenia study. Schizophrenia Research, 157(1-3), 142–148.
  • Wang, P. S., Demler, O., & Kessler, R. C. (2002). Adequacy of treatment for serious mental illness in the United States. American Journal of Public Health, 92(1), 92–98.
  • Wills, C. E., & Holmes-Rovner, M. (2006). Integrating decision making and mental health interventions research: Research directions. Clinical Psychology ( New York), 13(1), 9–25.